|View printer-friendly version|
|Ocular Therapeutix, Inc. Announces Pricing of Public Offering of Common Stock|
The offering is expected to close on or about
Before investing in the offering, interested parties may read the
prospectus supplement and the accompanying prospectus for the offering
and the other documents the Company has filed with the
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful, prior to registration or qualification under the securities laws of any such state or jurisdiction. Offers will be made only by means of a prospectus supplement and the accompanying prospectus, forming a part of the registration statement.
Forward Looking Statements